Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
LX-2006 by Lexeo Therapeutics for Friedreich Ataxia: Likelihood of Approval
LX-2006 is under clinical development by Lexeo Therapeutics and currently in Phase II for Friedreich Ataxia. According to GlobalData, Phase...
Data Insights
LX-2006 by Lexeo Therapeutics for Cardiomyopathy: Likelihood of Approval
LX-2006 is under clinical development by Lexeo Therapeutics and currently in Phase II for Cardiomyopathy. According to GlobalData, Phase II...